StonvexLoading…
StonvexStonvexStonvexCore line items from LRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $2.41B | $2.04B | $1.84B | $1.69B |
Operating Income | $360.09M | $249.60M | $165.50M | $156.63M |
Net Income | $287.94M | $204.18M | $126.87M | $107.13M |
EPS (Diluted) | $5.95 | $4.69 | $2.97 | $2.52 |
Total Assets | $2.29B | $1.92B | $1.76B | $1.64B |
Total Liabilities | $814.34M | $744.44M | $813.37M | $830.96M |
Cash & Equivalents | $782.50M | $500.61M | $410.81M | $389.40M |
Free Cash Flow OCF − CapEx | $431.04M | $276.53M | $198.81M | $197.14M |
Shares Outstanding | 43.52M | 43.24M | 43.00M | 42.78M |